Psychopharmacology of Aggression in Children and Adolescents with Autism: A Critical Review of Efficacy and Tolerability
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Autism is characterized by a clinical triad of symptoms that affect social, language, and behavioral domains. Aggression and self-injury may be associated symptoms of autism and can result in significant harm to those affected as well as marked distress for their families. The precise nature of the relationship between aggressive or self-injurious behavior (SIB) and autism remains unclear and as a result, these symptoms are treated with a broad range of pharmacological approaches. This review seeks to systematically and critically examine the evidence for the pharmacological management of aggression and SIB in children with autism spectrum disorders. METHOD: The entire PubMed database was searched for English language biomedical articles on clinical trials with medication in autism spectrum disorders. Studies were selected based on the following inclusion criteria: (1) randomized placebo-controlled trials; (2) a sample population that included children and adolescents; (3) at least one standardized assessment of aggression as a primary outcome measure of the study. RESULTS: Twenty one trials with 12 medications were identified. Five medications produced significant improvement as compared to placebo, including tianeptine, methylphenidate, risperidone, clonidine, and naltrexone. Only risperidone and methylphenidate demonstrate results that have been replicated across at least two studies. CONCLUSIONS: Although many medications have been studied under placebo-controlled conditions, few produce significant improvement. Additional placebo-controlled trials are needed to increase the number of therapeutic options available in the treatment of aggression in autism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Pervasive Developmental Disorders in preschool children
Chakrabarti, S. (2001) · JAMA · doi:10.1001/jama.285.24.3093 · Cited by 1,132 · cited 2×
“tion (Chakrabarti and Fombonne 2001), further studies should be conducted to determine the appropriateness of their use in children with autism.”
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300021 · Cited by 689 · cited 4×
“…range of symptoms in autism; most have included results from uncontrolled case reports and open-label trials, and few have highlighted the methodological limitations of the studies presented (Rothenberger 1993; King 2000; Hollander et al. 2003a; McDougle et al. 2003; Aman 2004, Malone et al. 2005).”
BackgroundInfluentialSelf-citationAntipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617 · cited 1×
“However, stimulant medications increase the availability of dopamine in the striatum, likely enhancing prefrontal cortical function though striatal-frontal pathways (Berridge et al. 2006) and improving inhibitory control.”
Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children
Schain, R. J., & Freedman, D. X. (1961) · The Journal of Pediatrics · doi:10.1016/s0022-3476(61)80261-8 · Cited by 579 · cited 1×
“Work that specifically examines the association between serotonergic regulation and autism dates back to 1961, when Schain and Freedman (1961) first reported elevated levels of whole-blood serotonin in a sub-group of individuals with autism.”
(2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1266 · Cited by 521
Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.201 · Cited by 438
Amminger, G. P., Berger, G. E., Schäfer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.007 · Cited by 355 · cited 2×
“One RCT has utilized a standardized assessment of aggression and self-injury to examine the efficacy of valproate in children and adolescents with autism, Asperger syndrome, and PDD-NOS.”
Clonidine Treatment of Hyperactive and Impulsive Children with Autistic Disorder
JASELSKIS, C. A., COOK, E. H., FLETCHER, K. E., & LEVENTHAL, B. L. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199210000-00005 · Cited by 328
Whole blood serotonin in autistic and normal subjects
Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R., & Young, J. G. (1987) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1987.tb00677.x · Cited by 313
Effects of tryptophan depletion in drug-free adults with autistic disorder
McDougle, C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110029004 · Cited by 301
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
CONNOR, D. F., FLETCHER, K. E., & SWANSON, J. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199912000-00017 · Cited by 297
GREENHILL, L. L., SWANSON, J. M., VITIELLO, B., DAVIES, M., CLEVENGER, W., WU, M., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00012 · Cited by 287
Autism and gastrointestinal symptoms
Horvath, K., & Perman, J. A. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0071-6 · Cited by 260 · cited 2×
“Second, researchers have proposed that secretin may impact central nervous system function through some as yet undetermined link between secretin receptors in the gastrointestinal system and certain regions of the developing brain (Horvath and Perman 2002).”
Hyperserotonemia and amine metabolites in autistic and retarded children
Hanley, H. G. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770170031002 · Cited by 230 · cited 2×
“1999), and approximately one third of individuals with autism are considered to have hyperserotonemia (Hanley et al. 1977).”
ARNOLD, L. E., VITIELLO, B., MCDOUGLE, C., SCAHILL, L., SHAH, B., GONZALEZ, N. M., CHUANG, S., DAVIES, M., HOLLWAY, J., AMAN, M. G., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200312000-00011 · Cited by 218 · cited 1×
“As part of the initial 8-week phase of the RUPP trial, Arnold et al. (2003) asked parents to identify one or two chief complaints of their child’s behavior at baseline.”
BackgroundNaltrexone in autistic children: Behavioral symptoms and attentional learning
CAMPBELL, M., ANDERSON, L. T., SMALL, A. M., ADAMS, P., GONZALEZ, N. M., & ERNST, M. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199311000-00024 · Cited by 210 · cited 2×
“The first was conducted by Campbell et al. (1993) in 41 children diagnosed with autistic disorder using a double-blind, placebo-controlled, parallel-group design over 4 weeks.”
Leboyer, M., Philippe, A., Bouvard, M., Guilloud-Bataille, M., Bondoux, D., Tabuteau, F., Feingold, J., Mouren-Simeoni, M.-C., & Launay, J.-M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00532-5 · Cited by 194
Paradoxical autonomic response to mental tasks in autism
Toichi, M., & Kamio, Y. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025062812374 · Cited by 122 · cited 1×
“Individuals with autism have been observed to experience hyperarousal in response to ambient stimuli (Toichi and Kamio 2003), and it is possible that children with autism may engage in SIB in an effort to reduce environmental stimulation (King 2000).”
Bouvard, M. P., Leboyer, M., Launay, J.-M., Recasens, C., Plumet, M.-H., Waller-Perotte, D., Tabuteau, F., Bondoux, D., Dugas, M., Lensing, P., et al. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02601-r · Cited by 112 · cited 4×
“-endorphin in some children and adolescents with autism (Sandman 1988; Ernst et al. 1993; Bouvard et al. 1995; Cazzullo et al. 1999; Leboyer et al. 1999).”
InfluentialRelationships of whole blood serotonin and plasma norepinephrine within families
Leventhal, B. L., Cook, E. H., Morford, M., Ravitz, A., & Freedman, D. X. (1990) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02216055 · Cited by 102
Retz, W., R�sler, M., Supprian, T., Retz-Junginger, P., & Thome, J. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0805-5 · Cited by 100
Dossenbach, M., Erol, A., Kessaci, M. E. M., Shaheen, M. O., Sunbol, M. M., Boland, J., Hodge, A., O'Halloran, R. A., Bitter, I., & IC-SOHO Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0305 · Cited by 80 · cited 1×
“According to studies in adult populations with schizophrenia, risperidone also has a lower risk of EPS and tardive dyskinesia (Dossenbach et al. 2004; Schooler et al. 2005).”
Gobbi, G., Gaudreau, P.-O., & Leblanc, N. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000237945.35022.45 · Cited by 74 · cited 1×
“…presence of seizure disorders in approximately one third of individuals with autism (Danielsson et al. 2005) and evidence of antiaggressive properties of valproate in animal and human models (Molina et al. 1986; Hollander et al. 2003b; Sival et al. 2004; Hollander et al. 2005b, Gobbi et al. 2006).”
Cited by
Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.201 · Cited by 438
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Mast cells, brain inflammation and autism
Theoharides, T. C., Stewart, J. M., Panagiotidou, S., & Melamed, I. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.086 · Cited by 138
Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
“Aggression and self-injury are also common, particularly in individuals with comorbid intellectual disability (Parikh et al, 2008; Volkmar et al, 1999).”
BackgroundPsychopharmacology in autism: an update
Canitano, R., & Scandurra, V. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.015 · Cited by 79
Metadata
- Authors
- Parikh, M. S., Kolevzon, A., & Hollander, E.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-04
- Volume
- 18
- Issue
- 2
- Pages
- 157-178
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2021724347
- Cited by
- 120
- References
- 25
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.